TRIPLE INCRETIN AGONIST
Retatrutide research — 10 mg vial, COA per batch
Retatrutide (LY3437943) is a multi-receptor agonist peptide. In preclinical research it is studied for its simultaneous interaction with GIP, GLP-1 and glucagon receptors in metabolic models.
What is Retatrutide?
Unlike semaglutide (mono-agonist) or tirzepatide (dual GLP-1/GIP), retatrutide simultaneously activates three incretin and glucagon receptors.
Research data from phase II clinical trials report an average 24% weight loss over 48 weeks, the highest of the incretin class to date.
Research domains
Product specifications
Reconstitution & storage
2 ml of bacteriostatic water gives 5 mg/ml. Store at 2–8°C for up to 28 days.
Open the peptide calculatorLab report & batch verification
Every batch of Retatrutide is independently analysed via HPLC and mass spectrometry. The Certificate of Analysis (COA) can be requested per batch ID by email and states purity, MW confirmation and residual solvents.
View all lab resultsShipping & storage
48h shipping
Orders placed before 15:00 CET ship the same business day from België.
Cold-chain
Insulated packaging with gel packs maintains 2–8°C for up to 72 hours.
Tracked & signed
Door-to-door tracking and signature on delivery, EU-wide.
Research & studies
Frequently asked questions about Retatrutide
Other research peptides
Ready to order Retatrutide?
10 mg vial, COA per batch, cold-chain shipped from België — usually delivered the next business day.
Order Retatrutide